Kumud Kalia - 01 May 2022 Form 3 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Information Officer
Signature
John Saia
Issuer symbol
GH
Transactions as of
01 May 2022
Net transactions value
$0
Form type
3
Filing time
11 May 2022, 20:54:15 UTC
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GH COMMON STOCK 20,530 01 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GH RESTRICTED STOCK UNITS 01 May 2022 COMMON STOCK 41,747 $0.000000 Direct F1, F2
holding GH STOCK OPTION (RIGHT TO BUY) 01 May 2022 COMMON STOCK 22,726 $117.61 Direct F3
holding GH STOCK OPTION (RIGHT TO BUY) 01 May 2022 COMMON STOCK 28,670 $74.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1)The Restricted Stock Units consist of three grants totaling 41,747 shares outstanding as of May 1, 2022. The first grant was granted on April 20, 2020, of which 10,751 shares are outstanding and vests 25% annually commencing on January 7, 2020. The second grant was granted on September 11, 2020, of which 19,633 shares are outstanding and vests 25% annually commencing on September 9, 2020. The third grant was granted on November 2, 2021, of which 11,363 shares are outstanding, and vests 25% on the first anniversary and quarterly thereafter commencing on September 1, 2021.
F2 Not applicable to Restricted Stock Units.
F3 The stock option vests and becomes exercisable as to 25% of the shares on September 1, 2022, and then in equal monthly installments through September 1, 2025.
F4 The stock option vests and becomes exercisable as to 25% of the shares on January 7, 2021, and then in equal monthly installments through January 7, 2024.